Armodafinil and Modafinil Prior Authorization (with Quantity Limit) Criteria – Medicare Part D
Prior Authorization and Quantity Limit Criteria for Approval
Armodafinil or modafinil will be approved when ALL of the following are met:
- The patient is at least 17 years of age
AND - The patient has an FDA labeled indication or an indication that is supported in CMS approved compendia for the requested medication
AND - The patient will NOT be using the requested medication in combination with another target medication (i.e., armodafinil OR modafinil)
AND - ONE of the following:
- The requested quantity (dose) does NOT exceed the program quantity limit
OR - ALL of the following:
- The requested quantity (dose) is greater than the program quantity limit
AND - The requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does not exceed the program quantity limit
AND - The prescriber has provided information in support of therapy with a higher dose for the requested indication
- The requested quantity (dose) is greater than the program quantity limit
- The requested quantity (dose) does NOT exceed the program quantity limit
Length of Approval: 12 months
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.